Article info
EBM opinion and debate
Improving FDA postmarket adverse event reporting for medical devices
- Correspondence to Dr Florence T Bourgeois, Boston Children's Hospital, Boston, MA 02115, USA; Florence.Bourgeois{at}childrens.harvard.edu
Citation
Improving FDA postmarket adverse event reporting for medical devices
Publication history
- Accepted January 21, 2022
- First published February 17, 2022.
Online issue publication
March 23, 2023
Article Versions
- Previous version (17 February 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.